Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11525181 | 0.84 | POLB (0.38) | POLBCYP3A4CYP2C9ABCB1SMN1; SMN2 | |
| SCHEMBL11797935 | 0.78 | POLB (0.35) | POLBCYP3A4CYP2C9ABCB1SMN1; SMN2 | |
| SCHEMBL11797946 | 0.78 | HTT (0.40) | POLBCYP3A4CYP2C9ABCB1SMN1; SMN2 | |
| SCHEMBL1644184 | 0.76 | POLB (0.35) | POLBCYP3A4CYP2C9 | |
| SCHEMBL1276936 | 0.75 | MEN1 (0.37) | POLBCYP3A4CYP2C9SMN1; SMN2 | |
| SCHEMBL17686051 | 0.75 | TSHR (0.35) | POLBCYP3A4CYP2C9 | |
| SCHEMBL4257189 | 0.71 | POLB (0.77) | POLBCYP3A4CYP2C9ABCB1 | |
| SCHEMBL1644186 | 0.70 | ALDH1A1 (0.32) | POLB | |
| SCHEMBL3317750 | 0.66 | CYP2D6 (0.41) | POLB | |
| Formic Acid SCHEMBL4660060 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6398938-B2 | WHERE THE ANODICALLY POLARIZED LAYER ON THE ANODE SUPPORT IS FORMED IN SITU BY PRECOATING; EXCLUDES THE OXIDATION OF PHOSPHONOMETHYLIMINODIACETIC ACID; HIGH YIELDS | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-04 | — | — | US | claimed |
| US-20010019020-A1 | Process for electrochemical oxidation of organic compounds | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-06 | — | — | US | claimed |
| EP-1111094-A2 | Process for the electrochemical oxidation of organic compounds | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-27 | — | — | EP | claimed |
| CN-119569879-A | Anti-B7-H3 antibody, antibody drug conjugate and medical application thereof | 杭州博之锐生物制药有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-118791622-A | Anti-ROR 1 antibodies and drug conjugates thereof | 浙江博锐生物制药有限公司 | 2024-10-18 | — | — | CN | disclosed |
| WO-2024213040-A1 | ANTI-ROR1 ANTIBODY AND DRUG CONJUGATE THEREOF | 浙江博锐生物制药有限公司 | 2024-10-17 | — | — | WO | disclosed |
| EP-3114109-A1 | INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS) | The Johns Hopkins University (US) | 2017-01-11 | — | — | EP | disclosed |
| WO-2015134973-A1 | INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS) | THE JOHNS HOPKINS UNIVERSITY (US) | 2015-09-11 | — | — | WO | disclosed |
| US-6398938-B2 | WHERE THE ANODICALLY POLARIZED LAYER ON THE ANODE SUPPORT IS FORMED IN SITU BY PRECOATING; EXCLUDES THE OXIDATION OF PHOSPHONOMETHYLIMINODIACETIC ACID; HIGH YIELDS | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-04 | — | — | US | disclosed |
| US-20010019020-A1 | Process for electrochemical oxidation of organic compounds | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-06 | — | — | US | disclosed |
| EP-1111094-A2 | Process for the electrochemical oxidation of organic compounds | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-27 | — | — | EP | disclosed |